UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 557

Sortiert nach

A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status

Clinical cancer research, 2007-10, Vol.13 (19), p.5680-5691

2007

Volltextzugriff (PDF)

IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas

Clinical cancer research, 2001-06, Vol.7 (6), p.1812-1820

2001

Volltextzugriff (PDF)

Expression of Proinflammatory and Proangiogenic Cytokines in Patients with Head and Neck Cancer

Clinical cancer research, 1999-06, Vol.5 (6), p.1369-1379

1999

Volltextzugriff (PDF)

Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (16), p.7071-7080

2005

Volltextzugriff (PDF)

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-κB and activator protein-1 related mechanisms

Molecular cancer therapeutics, 2008-07, Vol.7 (7), p.1949-1960

2008

Volltextzugriff (PDF)

A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma

Head & neck, 2005-09, Vol.27 (9), p.771-784

2005

Volltextzugriff (PDF)

Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor

Oncogene, 2004-08, Vol.23 (37), p.6199-6208

2004

Volltextzugriff (PDF)

A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas

International journal of cancer, 2008-05, Vol.122 (9), p.1987-1998

2008

Volltextzugriff (PDF)

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines

International journal of cancer, 2002-06, Vol.99 (4), p.538-548

2002

Volltextzugriff (PDF)

Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma

Cancer research (Chicago, Ill.), 2001-08, Vol.61 (15), p.5911-5918

2001

Volltextzugriff (PDF)

A signal network involving coactivated NF- mu B and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas

International journal of cancer, 2008-05, Vol.122 (9), p.1987-1998

2008

Volltextzugriff (PDF)

A signal network involving coactivated NF-KB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas

International journal of cancer, 2008, Vol.122 (9), p.1987-1998

2008

Volltextzugriff (PDF)

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, NF-κB and AP-1 related mechanisms

Molecular cancer therapeutics, 2008-07, Vol.7 (7), p.1949-1960

2008

Volltextzugriff (PDF)

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms

Molecular cancer therapeutics, 2008-07, Vol.7 (7), p.1949

2008

Volltextzugriff (PDF)

A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status

Clinical cancer research, 2007-10, Vol.13 (19), p.5680-5691

2007

Volltextzugriff (PDF)

A novel nuclear factor-κB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Commentary

Clinical cancer research, 2007, Vol.13 (19)

2007

Volltextzugriff (PDF)

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines

International journal of cancer, 2002-06, Vol.99 (4), p.538-548

2002

Volltextzugriff (PDF)

A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas

International journal of cancer, 2008-05, Vol.122 (9), p.1987-1998

2008

Volltextzugriff (PDF)

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines

International journal of cancer, 2002, Vol.99 (4), p.538-548

2002

Volltextzugriff (PDF)

The C‐degron pathway eliminates mislocalized proteins and products of deubiquitinating enzymes

The EMBO journal, 2021-04, Vol.40 (7), p.e105846-n/a

2021

Volltextzugriff (PDF)

Binder-free graphene oxide doughs

Nature communications, 2019-01, Vol.10 (1), p.422-422, Article 422

2019

Volltextzugriff (PDF)

A Cut‐and‐Paste Approach to 3D Graphene‐Oxide‐Based Architectures

Advanced materials (Weinheim), 2018-04, Vol.30 (15), p.e1706229-n/a

2018

Volltextzugriff (PDF)

Estrogen Receptor α Represses Transcription of HBV Genes via Interaction With Hepatocyte Nuclear Factor 4α

Gastroenterology (New York, N.Y. 1943), 2012-04, Vol.142 (4), p.989-998.e4

2012

Volltextzugriff (PDF)

Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry

BMC nephrology, 2024-04, Vol.25 (1), p.133-133, Article 133

2024

Volltextzugriff (PDF)

Downregulation of miR‐29 contributes to cisplatin resistance of ovarian cancer cells

International journal of cancer, 2014-02, Vol.134 (3), p.542-551

2014

Volltextzugriff (PDF)

1 – 25 von 557

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(465)
Mit Volltextzugriff
(495)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status

IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas

Expression of Proinflammatory and Proangiogenic Cytokines in Patients with Head and Neck Cancer

Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-κB and activator protein-1 related mechanisms

A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma

Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor

A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines

Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma

A signal network involving coactivated NF- mu B and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas

A signal network involving coactivated NF-KB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, NF-κB and AP-1 related mechanisms

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms

A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status

A novel nuclear factor-κB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Commentary

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines

A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-KB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines

The C‐degron pathway eliminates mislocalized proteins and products of deubiquitinating enzymes

Binder-free graphene oxide doughs

A Cut‐and‐Paste Approach to 3D Graphene‐Oxide‐Based Architectures

Estrogen Receptor α Represses Transcription of HBV Genes via Interaction With Hepatocyte Nuclear Factor 4α

Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry

Downregulation of miR‐29 contributes to cisplatin resistance of ovarian cancer cells

Suchergebnisse filtern